Loading clinical trials...
Loading clinical trials...
Contrast-associated acute kidney injury (CI-AKI) is a sudden and significant decline in renal function resulting from the use of a contrast agent.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Xiao Li,MD
NCT07106151 · AKI, AKI - Acute Kidney Injury, and more
NCT07294859 · Nephrectomy, Renal Cell Cancer, and more
NCT06543940 · AKI - Acute Kidney Injury
NCT06811805 · AKI - Acute Kidney Injury, Cardiac Surgery Associated - Acute Kidney Injury
NCT07317817 · Sepsis, ARDS (Acute Respiratory Distress Syndrome), and more
The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital
Jinan, Shandong
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions